Christopher P. Holroyde

1.5k total citations
18 papers, 1.2k citations indexed

About

Christopher P. Holroyde is a scholar working on Physiology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher P. Holroyde has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 6 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher P. Holroyde's work include Diet and metabolism studies (6 papers), Neonatal Health and Biochemistry (3 papers) and Cancer Treatment and Pharmacology (3 papers). Christopher P. Holroyde is often cited by papers focused on Diet and metabolism studies (6 papers), Neonatal Health and Biochemistry (3 papers) and Cancer Treatment and Pharmacology (3 papers). Christopher P. Holroyde collaborates with scholars based in United States and South Korea. Christopher P. Holroyde's co-authors include Georg Reichard, Frank H. Gardner, Pavle Paul, C L Skutches, P Paul, Thomas G. Gabuzda, Richard N. Myers, Agnes C. Haff, Frank A. Oski and Guenther Boden and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Christopher P. Holroyde

18 papers receiving 1.1k citations

Peers

Christopher P. Holroyde

PHYSI

SURGE

PRM

G Svaninger Sweden

Merry J.G. Bolt United States

Michael E. Ullian United States

Matthew J. Sheetz United States

F Fyhrquist Finland

Daniel Giannella‐Neto Brazil

Theresa W. Gauthier United States

Martin Press United Kingdom

Loredana Mura Italy

T. M. Chalmers United Kingdom

G Svaninger Sweden

Christopher P. Holroyde

462 ×0.8

PHYSI

206 ×0.7

211 ×0.8

SURGE

210 ×1.1

65 ×0.4

PRM

Citations per year, relative to Christopher P. Holroyde Christopher P. Holroyde (= 1×) peers G Svaninger

Countries citing papers authored by Christopher P. Holroyde

Since Specialization

Citations

This map shows the geographic impact of Christopher P. Holroyde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Holroyde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Holroyde more than expected).

Fields of papers citing papers by Christopher P. Holroyde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Holroyde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Holroyde. The network helps show where Christopher P. Holroyde may publish in the future.

Co-authorship network of co-authors of Christopher P. Holroyde

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Holroyde. A scholar is included among the top collaborators of Christopher P. Holroyde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Holroyde. Christopher P. Holroyde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Rathmell, W. Kimryn, et al.. (2004). Phase II Trial of 5-Fluorouracil and Leucovorin in Combination With Interferon-alpha and Interleukin-2 for Advanced Renal Cell Cancer. American Journal of Clinical Oncology. 27(2). 109–112. 5 indexed citations

Stein, Steven, Thomas Peacock, Christopher P. Holroyde, et al.. (2001). Phase II Trial of Toremifene in Androgen-Independent Prostate Cancer. American Journal of Clinical Oncology. 24(3). 283–285. 21 indexed citations

Vaughn, David J., et al.. (2000). A Phase II Trial of 5-Fluorouracil, Leucovorin, and Interferon Alpha 2A (IFN-α 2a) in Metastatic Pancreatic Carcinoma. American Journal of Clinical Oncology. 23(1). 37–39. 11 indexed citations

Vaughn, David J., S. Bruce Malkowicz, Rosemarie Mick, et al.. (1998). Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen.. Journal of Clinical Oncology. 16(1). 255–260. 117 indexed citations

Vaughn, David J., N J Meropol, Christopher P. Holroyde, et al.. (1997). A Phase II Study of 5-Fluorouracil, Leucovorin, Adriamycin, and Cisplatin (FLAP) for Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma. American Journal of Clinical Oncology. 20(3). 242–246. 6 indexed citations

Lane, Montague, Charles L. Vogel, Steven H. Krasnow, et al.. (1991). Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting. Journal of Pain and Symptom Management. 6(6). 352–359. 91 indexed citations

Hietala, Oili A., Kevin O’Donnell, Christopher P. Holroyde, et al.. (1990). Properties of ornithine decarboxylase in human colorectal adenocarcinomas.. PubMed. 50(7). 2088–94. 23 indexed citations

Holroyde, Christopher P. & Georg Reichard. (1986). General Metabolic Abnormalities in Cancer Patients: Anorexia and Cachexia. Surgical Clinics of North America. 66(5). 947–956. 29 indexed citations

Holroyde, Christopher P., et al.. (1984). Glucose metabolism in cachectic patients with colorectal cancer.. PubMed. 44(12 Pt 1). 5910–3. 103 indexed citations

10.

Glick, John H., et al.. (1981). Randomized clinical trial of tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal women with advanced breast cancer. Breast Cancer Research and Treatment. 1(1). 59–68. 20 indexed citations

11.

Glick, John H., et al.. (1980). Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: A randomized trial. Cancer. 45(4). 735–741. 26 indexed citations

12.

Holroyde, Christopher P., et al.. (1979). Lactate metabolism in patients with metastatic colorectal cancer.. PubMed. 39(12). 4900–4. 59 indexed citations

13.

Skutches, C L, Christopher P. Holroyde, Richard N. Myers, P Paul, & Georg Reichard. (1979). Plasma acetate turnover and oxidation.. Journal of Clinical Investigation. 64(3). 708–713. 137 indexed citations

14.

Reichard, Georg, Agnes C. Haff, C L Skutches, et al.. (1979). Plasma Acetone Metabolism in the Fasting Human. Journal of Clinical Investigation. 63(4). 619–626. 130 indexed citations

15.

Holroyde, Christopher P., et al.. (1977). Metabolic response to total parenteral nutrition in cancer patients.. PubMed. 37(9). 3109–14. 42 indexed citations

16.

Holroyde, Christopher P., et al.. (1975). Altered glucose metabolism in metastatic carcinoma.. PubMed. 35(12). 3710–4. 197 indexed citations

17.

Holroyde, Christopher P. & Frank H. Gardner. (1970). Acquisition of Autophagic Vacuoles by Human Erythrocytes Physiological Role of the Spleen. Blood. 36(5). 566–575. 85 indexed citations

18.

Holroyde, Christopher P., Frank A. Oski, & Frank H. Gardner. (1969). The Pocked Erythrocyte. New England Journal of Medicine. 281(10). 516–520. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact